Jeff Mirviss is the EVP and President of Peripheral Interventions at Boston Scientific. With over 31 years in medical devices and pharmaceuticals, he has played a crucial role in developing innovative solutions for treating arterial and venous system blockages and cancer. Since joining Boston Scientific in 1997, he has held key leadership roles in cardiology and vascular health. Jeff holds a bachelor’s degree from the University of Minnesota and an MBA from the University of St. Thomas.